1394 related articles for article (PubMed ID: 19243060)
21. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
22. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced MR angiography in rats with hepatobiliary contrast agents.
Yoshikawa K; Inoue Y; Shimada M; Akahane M; Itoh S; Seno A; Hayashi S
Magn Reson Imaging; 2004 Sep; 22(7):937-42. PubMed ID: 15288134
[TBL] [Abstract][Full Text] [Related]
24. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
25. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
[TBL] [Abstract][Full Text] [Related]
26. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
27. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
[TBL] [Abstract][Full Text] [Related]
28. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
29. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of renal function in normal and hydronephrotic kidneys in rats using gadolinium diethylenetetramine-pentaacetic acid enhanced dynamic magnetic resonance imaging.
Wen JG; Chen Y; Ringgaard S; Frøkiaer J; Jørgensen TM; Stødkilde-Jørgensen H; Djurhuus JC
J Urol; 2000 Apr; 163(4):1264-70. PubMed ID: 10737526
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
32. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
Higaki A; Tamada T; Sone T; Kanki A; Sato T; Tanimoto D; Higashi H; Ito K
Magn Reson Imaging; 2012 Jun; 30(5):689-93. PubMed ID: 22459437
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
34. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
[TBL] [Abstract][Full Text] [Related]
35. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
[TBL] [Abstract][Full Text] [Related]
36. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.
Saito K; Ledsam J; Sourbron S; Otaka J; Araki Y; Akata S; Tokuuye K
J Magn Reson Imaging; 2013 May; 37(5):1109-14. PubMed ID: 23086736
[TBL] [Abstract][Full Text] [Related]
37. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
[TBL] [Abstract][Full Text] [Related]
38. Arterial visualization by contrast-enhanced moving-table MR angiography: crossover comparison of 0.1 and 0.2 mmol/kg doses of meglumine gadopentetate in normal volunteers.
Hayashi H; Yuasa Y; Amano Y; Tanimoto A; Saito Y; Yoshioka K; Kita M; Kumazaki T; Hiramatsu K
J Magn Reson Imaging; 2008 Sep; 28(3):783-90. PubMed ID: 18777556
[TBL] [Abstract][Full Text] [Related]
39. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
40. Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.
Verloh N; Haimerl M; Zeman F; Teufel A; Lang S; Stroszczynski C; Fellner C; Wiggermann P
Rofo; 2015 Jan; 187(1):29-35. PubMed ID: 25531338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
